Jul 29, 2026 08:30AM

Jul 29, 2026 08:30AM

Jul 8, 2026 08:30PM

Jul 7, 2026 09:43AM

Apr 28, 2026 09:00PM

Mar 26, 2026 10:08AM

Feb 5, 2026 08:00AM Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications

Jan 23, 2026 08:30AM

328,143 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All